Alterity Therapeutics (Australia) Market Value
| ATH Stock | 0.01 0.0005 5.88% |
| Symbol | Alterity |
Alterity Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Alterity Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Alterity Therapeutics.
| 01/03/2025 |
| 12/29/2025 |
If you would invest 0.00 in Alterity Therapeutics on January 3, 2025 and sell it all today you would earn a total of 0.00 from holding Alterity Therapeutics or generate 0.0% return on investment in Alterity Therapeutics over 360 days. Alterity Therapeutics is related to or competes with Fisher Paykel, Healthco Healthcare, Retail Food, Autosports, Oceania Healthcare, and Super Retail. Alterity Therapeutics is entity of Australia More
Alterity Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Alterity Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Alterity Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.02) | |||
| Maximum Drawdown | 36.11 | |||
| Value At Risk | (11.11) | |||
| Potential Upside | 12.5 |
Alterity Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Alterity Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Alterity Therapeutics' standard deviation. In reality, there are many statistical measures that can use Alterity Therapeutics historical prices to predict the future Alterity Therapeutics' volatility.| Risk Adjusted Performance | 0.0025 | |||
| Jensen Alpha | 0.0866 | |||
| Total Risk Alpha | (0.95) | |||
| Treynor Ratio | 0.0377 |
Alterity Therapeutics Backtested Returns
Alterity Therapeutics appears to be out of control, given 3 months investment horizon. Alterity Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0265, which signifies that the company had a 0.0265 % return per unit of risk over the last 3 months. We have found twenty-three technical indicators for Alterity Therapeutics, which you can use to evaluate the volatility of the firm. Please makes use of Alterity Therapeutics' Risk Adjusted Performance of 0.0025, mean deviation of 5.5, and Standard Deviation of 8.08 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Alterity Therapeutics holds a performance score of 2. The firm shows a Beta (market volatility) of -2.31, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Alterity Therapeutics are expected to decrease by larger amounts. On the other hand, during market turmoil, Alterity Therapeutics is expected to outperform it. Please check Alterity Therapeutics' maximum drawdown, potential upside, kurtosis, as well as the relationship between the value at risk and skewness , to make a quick decision on whether Alterity Therapeutics' price patterns will revert.
Auto-correlation | 0.12 |
Insignificant predictability
Alterity Therapeutics has insignificant predictability. Overlapping area represents the amount of predictability between Alterity Therapeutics time series from 3rd of January 2025 to 2nd of July 2025 and 2nd of July 2025 to 29th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Alterity Therapeutics price movement. The serial correlation of 0.12 indicates that less than 12.0% of current Alterity Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.12 | |
| Spearman Rank Test | -0.23 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Alterity Therapeutics lagged returns against current returns
Autocorrelation, which is Alterity Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Alterity Therapeutics' stock expected returns. We can calculate the autocorrelation of Alterity Therapeutics returns to help us make a trade decision. For example, suppose you find that Alterity Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Alterity Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Alterity Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Alterity Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Alterity Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Alterity Therapeutics Lagged Returns
When evaluating Alterity Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Alterity Therapeutics stock have on its future price. Alterity Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Alterity Therapeutics autocorrelation shows the relationship between Alterity Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Alterity Therapeutics.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Alterity Stock Analysis
When running Alterity Therapeutics' price analysis, check to measure Alterity Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alterity Therapeutics is operating at the current time. Most of Alterity Therapeutics' value examination focuses on studying past and present price action to predict the probability of Alterity Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alterity Therapeutics' price. Additionally, you may evaluate how the addition of Alterity Therapeutics to your portfolios can decrease your overall portfolio volatility.